COMP <GO>
LHX vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
L3Harris Technologies Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: LHX 6
— TMO 7
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: TMO
LAST: $277.61 (-0.29%) • MKT CAP: $51.85B
options-implied-move
6.80%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
options-implied-move
6.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LHX VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LHX | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.70% | 9.30% | -3.60 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.8x | 30.4x | -5.60 | LHX | /valuation <GO> |
| Free Cash Flow Yield | 5.17% | 2.40% | +2.77 | LHX | /fcf-yield <GO> |
| Operating Margin | 14.50% | 17.40% | -2.90 | TMO | /operating-margins <GO> |
| Net Profit Margin | 11.10% | 15.10% | -4.00 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -31.90% | 3.90% | -35.80 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.74% | 0.24% | +1.50 | LHX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.15 | 4.50 | -2.35 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 76.2 | 59.1 | +17.08 | LHX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.94 | +0.02 | LHX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.0x | 36.3x | -6.30 | LHX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $51.85B | $262.22B | -$210.37B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LHX REV | TMO REV | LHX GROSS % | TMO GROSS % | LHX FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $44.56B | — | 44.0% | $2.68B | $6.29B |
| FY 2024 | $21.32B | $42.88B | 25.9% | 44.0% | $2.15B | $7.27B |
| FY 2023 | $19.42B | $42.86B | 44.0% | 44.0% | $1.22B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LHX // BETA 0.96
TMO // BETA 0.94